News

As per the terms of the agreement, Perrigo acquired 100% of the shares of PBM Holdings for $808m in cash. Pursuant to the agreement, Perrigo and PBM expect

Prior to joining GVK Bio, Dr Ellingboe worked with Wyeth Research and Pfizer for 25 years in senior scientific positions and has extensive background in medicinal chemistry and

The license granted by Genetic Technologies covers the world-wide activities of Gen-Probe in relation to its genetic diagnostics and analysis products. Discussions between Genetic Technologies and Gen-Probe commenced

Reportedly, FDA was notified by the New York City Department of Health and Mental Hygiene about a patient with lead poisoning who reported taking Vita Breath and two

NiKem Research said that Toxicokinetic (TK) studies are allowed to correlate plasma and/or organ exposure of NCEs (and metabolites) to tolerated doses in toxicology studies. NiKem Research has

Mr Russell will report to John Chiminski, president and CEO of Catalent, and will be based in Catalent’s Philadelphia packaging facility. David Heyens, the current incumbent, will simultaneously

DSM Biologics is a business unit of DSM Pharmaceutical Products (DPP), a global business providing cGMP custom manufacturing services across all facets of the pharmaceutical industry including small

As per the terms of the agreement, Glenmark is expected to receive an upfront payment as well as development, regulatory and commercial milestone payments from Sanofi-aventis. All such

RaySearch Laboratories said that the Eclipse software currently incorporates three RaySearch developments, including tools for biological evaluation, biological optimisation, and conformal optimisation. Johan Lof, CEO of RaySearch Laboratories,